Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study

Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study

Abstract Background Data on the prevalence of perennial versus seasonal allergic asthma in Italy are lacking; moreover, there is limited evidence on the effect of omalizumab on patient-reported outcomes in Italian patients with severe allergic asthma. PROXIMA, an observational, multicenter study, wa...

Full description

Bibliographic Details
Main Authors: Giorgio Walter Canonica, Paola Rottoli, Caterina Bucca, Maria Cristina Zappa, Giovanni Michetti, Bruno Macciocchi, Cristiano Caruso, Pierachille Santus, Marta Bartezaghi, Laura Rigoni, on behalf of PROXIMA study centers
Format: Article
Language:English
Published: Elsevier 2018-11-01
Series:World Allergy Organization Journal
Subjects:
Omalizumab
Severe allergic asthma
Asthma control
Exacerbations
Quality of life
Perennial allergens
Online Access:http://link.springer.com/article/10.1186/s40413-018-0214-3

Internet

http://link.springer.com/article/10.1186/s40413-018-0214-3

Similar Items